Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ : 2022-06-16±³À°ÀÏÀÚ : 2022-06-16
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È»ó °ÀÇ) ¹× ¼¿ï·Ôµ¥È£ÅÚ 2, 3Ãþ 5°³·ë
±³À°ÁÖÁ¦ :
(¿Â∙¿ÀÇÁ¶óÀÎ º´Çà) Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486
À̸ÞÀÏ :
cancer2@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 22 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í 1. ȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 10¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 5¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 10¸¸¿ø2. ºñȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 15¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 5¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 20¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-16 Room A 08:40~09:05 Human carcinogens in Asia Ian A Cree(World Health Organization, France)
±³À°½Ã°£ 06-16 Room A 09:05~09:30 Diet and cancer risk in Asia ÀÌÁ¤Àº(¼¿ï´ë »ý°ú´ë)
±³À°½Ã°£ 06-16 Room A 09:30~09:55 Modifiable and unmodifiable risk factors for cancer in Asia Manami Inoue(National Cancer Center, Japan)
±³À°½Ã°£ 06-16 Room A 09:55~10:20 Current Status and prevention of Occupational carcinogen exposure in Asia ±èÀξÆ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 06-16 Room B 08:40~09:05 Cryo-EM study of transmembrane protein and antibody complexes ÀÌÁö¿À(POSTECH)
±³À°½Ã°£ 06-16 Room B 09:05~09:30 Proteomics and application in translational research ±è°æ°ï(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-16 Room B 09:30~09:55 Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer Adriana Franco Paes Leme(Brazilian Biosciences National Laboratory (LNBio), Brazil)
±³À°½Ã°£ 06-16 Room B 09:55~10:20 Machine learning powered next-generation proteomics Lennart Martens(Ghent University, Belgium)
±³À°½Ã°£ 06-16 Room D 08:40~09:05 Network-based machine-learning to predict drug efficacy in cancer patients ±è»ó¿í(POSTECH)
±³À°½Ã°£ 06-16 Room D 09:05~09:30 Applications of machine learning in cancer immunotherapy ÃÖÁ¤±Õ(KAIST)
±³À°½Ã°£ 06-16 Room D 09:30~09:55 AI on spatial tranome guides pathological decision making in cancer ÀÌÁÖ»ó(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-16 Room D 09:55~10:20 Exploring phenotype patterns of breast cancer within somatic mutations Hiroshi Mamitsuka(Kyoto University, Japan)
±³À°½Ã°£ 06-16 Room E 08:40~09:05 Diagnosis of hereditary breast-ovarian cancer syndrome ±èÁ¾¿ø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-16 Room E 09:05~09:30 Cancer screening recommendations for individuals with Li-Fraumeni syndrome Mandy Ballinger(Garvan Institute of Medical Research, Australia)
±³À°½Ã°£ 06-16 Room E 09:30~09:55 Screening and management of individuals with neurofibromatosis 1 ±èÇý¸®(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-16 Room E 09:55~10:20 Molecular characteristics, screening, and treatment of hereditary breast and ovarian cancer Reiko Yoshida(Showa University, Japan)
ÈÞ½Ä 06-16 10:20~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 06-16 Room A 10:40~11:20 Dynamic changes of tumor infiltrating immune cells during immunotherapies Zemin Zhang(Peking University, China)
±³À°½Ã°£ 06-16 Room A 11:20~12:00 The barriers in clinical application of cancer precision medicine: Lessons K-MASTER project ±è¿È«(°í·ÁÀÇ´ë)
½Ä»ç 06-16 12:00~12:30 ½Ä»ç ()
±³À°½Ã°£ 06-16 Room A 12:30~13:10 A new approval of novel combination, pembrolizumab plus lenvatinib in advanced RCC with CLEAR (KN581) data ±èÀÎÈ£(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-16 Room D 12:30~13:10 Sotorasib, the first target therapy for kras g12c mt. NSCLC ¹ÌÁ¤()
ÈÞ½Ä 06-16 13:10~13:25 ÈÞ½Ä ()
±³À°½Ã°£ 06-16 Room A 13:25~13:50 Molecular carcinogenesis of cholangiocarcinoma Teh Bin Tean(National Cancer Center Singapore, Singapore)
±³À°½Ã°£ 06-16 Room A 13:50~14:15 Liver transplantation for HCC À̱¤¿õ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-16 Room A 14:15~14:40 Radiotherapy Angela Gilselvania(Cipto Mangunkusumo National General Hospital, Indonesia)
±³À°½Ã°£ 06-16 Room A 14:40~15:05 Emerging therapeutic options for HCC and cholangiocarcinoma ±èÅ¿ë(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 06-16 Room B 13:25~13:50 To be announced Ross Soo(National University Cancer Institute, Singapore)
±³À°½Ã°£ 06-16 Room B 13:50~14:15 Modulation of tumor immune responses by dead cell-derived molecules Hideyuki Yanai(University of Tokyo, Japan)
±³À°½Ã°£ 06-16 Room B 14:15~14:40 Towards next generation T cell engineering for cancer immunotherapy ±èÂùÇõ(KAIST)
±³À°½Ã°£ 06-16 Room B 14:40~15:05 To be announced ÀÓ¼¼Áø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-16 Room D 13:25~13:50 Integrating digital pathology into clinical practice Á¤Âù±Ç(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-16 Room D 13:50~14:15 Digitized network for pathologic diagnosis in Japan Junya Fukuoka(Nagasaki University Graduate School of Biomedical Sciences, Japan)
±³À°½Ã°£ 06-16 Room D 14:15~14:40 Digital pathology project in Korea Àå±âÅÃ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-16 Room D 14:40~15:05 Application of deep learning for cancer histological grading Mattias Rantalainen(Karolinska Institutet, Sweden)
±³À°½Ã°£ 06-16 Room E 13:25~13:55 Review of ctDNA analysis in patients with cancer Jason D. Merker(University of North Carolina School of Medicine, USA)
±³À°½Ã°£ 06-16 Room E 13:55~14:25 Monitoring minimal residual disease based on ctDNA in breast cancer ÇÑ¿ø½Ä(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-16 Room E 14:25~14:55 Liquid biopsy for advanced NSCLC - IASLC consensus statement Daniel Tan Shao Weng(National Cancer Center Singapore, Singapore)
Åä·Ð 06-16 Room E 14:55~15:05 Q&A Discussion ()
ÈÞ½Ä 06-16 15:05~15:25 ÈÞ½Ä ()
±³À°½Ã°£ 06-16 Room A 15:25~15:45 Epidemiology of gastric cancer in Asia Manami Inoue(National Cancer Center, Japan)
±³À°½Ã°£ 06-16 Room A 15:45~16:05 Surgical oncology in Japan Yasuhiro Kodera(Nagoya University, Japan)
±³À°½Ã°£ 06-16 Room A 16:05~16:25 Surgical oncology in China Jiafu Ji(Beijing Cancer Hospital, China)
±³À°½Ã°£ 06-16 Room A 16:25~16:45 Medical oncology in the East ¿Àµµ¿¬(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-16 Room A 16:45~17:05 Medical oncology in the West Yelena Janjigian(Memorial Sloan Kettering Cancer Center, USA)
±³À°½Ã°£ 06-16 Room B 15:25~15:50 Efficacy of 3-dimensional printed breast surgical guide in breast conserving surgery °í¹ü¼®(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 06-16 Room B 15:50~16:15 Cutting edge technology of intraoperative near-infrared fluorescence Image during thoracic tumor surgery ±èÇö±¸(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-16 Room B 16:15~16:40 Application of fluorescence imaging to liver cancer surgery Xiaoying Wang(Liver Cancer Institute, Zhongshan Hospital, Fudan University, China)
±³À°½Ã°£ 06-16 Room B 16:40~17:05 Utility of intraoperative fluorescence imaging in gynecologic cancer surgery Mikel Gorostidi Pulgar(Donostia Hospital, Spain)
±³À°½Ã°£ 06-16 Room D 15:25~15:50 Application of artificial intelligence in radiation oncology Steve B. Jiang(University of Texas Southwestern Medical Center, USA)
±³À°½Ã°£ 06-16 Room D 15:50~16:15 Autosegmentation of target volume and normal organ delineation Norman Zhu(Manteia Medical Technologies Co., China)
±³À°½Ã°£ 06-16 Room D 16:15~16:40 Ultra-high dose rate (FLASH) radiotherapy Hiromitsu Iwata(Nagoya Proton Therapy Center, Japan)
±³À°½Ã°£ 06-16 Room D 16:40~17:05 Proton minibeam technique for clinical application ÀÓ¿µ°æ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 06-16 Room E 15:25~15:50 MRD in hematologic oncology Anthony S. Stein(City of Hope, USA)
±³À°½Ã°£ 06-16 Room E 15:50~16:15 The role of Flow-, PCR- and NGS-based MRD in hematologic malignancies ±è¸í½Å(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-16 Room E 16:15~16:40 Analysis of cfDNA in colon cancer Claus Lindbjerg Andersen(Aarhus University Hospital, Denmark)
±³À°½Ã°£ 06-16 Room E 16:40~17:05 Liquid Bx for MRD of breast cancer ÀÌÇѺ°(¼¿ï´ëº´¿ø)